RUDDEROW v. BOSTON SCIENTIFIC CORPORATION

CourtDistrict Court, D. New Jersey
DecidedMay 12, 2022
Docket1:20-cv-08561
StatusUnknown

This text of RUDDEROW v. BOSTON SCIENTIFIC CORPORATION (RUDDEROW v. BOSTON SCIENTIFIC CORPORATION) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
RUDDEROW v. BOSTON SCIENTIFIC CORPORATION, (D.N.J. 2022).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

SHARON RUDDEROW and ROBERT RUDDEROW, Civil Action No. 20-08561 (CPO) Plaintiffs,

v. OPINION

BOSTON SCIENTIFIC CORPORATION, JOHN AND JANE DOES 1–10, AND ABC CORPS. 1–10,

Defendants.

Appearances: Adam M. Slater Julia S. Slater MAZIE SLATER KATZ & FREEMAN 103 Eisenhower Parkway, Suite 207 Roseland, NJ 07068

On behalf of Plaintiffs Sharon and Robert Rudderow.

James Holsey Keale TANENBAUM KEALE, LLP Three Gateway Center 100 Mulberry Street, Suite 1301 Newark, NJ 07102

Marina Mcguire TANENBAUM KEALE, LLP One Newark Center 1085 Raymond Boulevard, 16th Floor Newark, NJ 07102

On behalf of Defendant Boston Scientific Corporation. O’HEARN, District Judge. I. INTRODUCTION This matter comes before the Court on Mazie Slater Katz & Freeman, LLC’s (“Mazie Slater” or “MS”) Motion to Set a Reasonable Fee, (ECF No. 42), and Motion to Seal, (ECF No. 75). The Court did not hear oral argument pursuant to Local Civil Rule 78.1.1 For the reasons

discussed below, the Motion to Set a Reasonable Fee is GRANTED IN PART AND DENIED IN PART. The Motion to Seal is GRANTED. II. BACKGROUND The Court recites herein only those facts necessary to provide a brief background and resolve the pending Motions. This is a products liability case concerning the use of transvaginal surgical mesh to treat pelvic organ prolapse. (MS Reasonable Fee Br., ECF No. 43, at 1–2). On June 30, 2010, Plaintiff Sharon Rudderow was surgically implanted with the Uphold Vaginal Support System (“the Uphold”), a device manufactured and sold by Boston Scientific Corporation. (MS Reasonable Fee

Br., ECF No. 43, at 2). She suffered, and continues to suffer, significant injuries as a result of the Uphold. (MS Reasonable Fee Br., ECF No. 43, at 2). In 2016, shortly after filing their initial lawsuit, Plaintiffs replaced their initial counsel with Mazie Slater after having been dissatisfied with the quality of representation. (MS Reasonable Fee Br., ECF No. 43, at 2–3). The first serious settlement negotiations began in 2019, while the case was a part of the pelvic mesh Multi-District Litigation (“MDL”). (MS Reasonable Fee Br., ECF No. 43, at 3). After mediation was not successful, Plaintiffs re-filed their case in this Court on

1 The Court initially noticed this matter for argument, (ECF No. 90), however, Plaintiffs advised the Court that, while they opposed any award of a fee to Mazie Slater, they would be unable to appear for argument, (ECF No. 92). September 9, 2022 and began discovery. (MS Reasonable Fee Br., ECF No. 43, at 3). After a second mediation on August 25, 2021, the parties reached a settlement in excess of $3,000,000. (MS Reasonable Fee Br., ECF No. 43, at 2–3). Mazie Slater subsequently filed the two motions that the Court now addresses. First, Mazie

Slater filed a Motion to Set a Reasonable Fee, (ECF No. 42), which Plaintiffs, Sharon and Robert Rudderow acting pro se,2 opposed, (ECF Nos. 55, 56). Second, Mazie Slater filed a Motion to Seal, (ECF No. 75), seeking to permanently seal Mazie Slater’s Memorandum of Law in Support of Motion to Set a Reasonable Fee, (ECF No. 43), Adam M. Slater, Esquire’s Certification in Support of that Motion, (ECF No. 43-1), the associated Proposed Order, (ECF No. 43-2), Mazie Slater’s December 6, 2021 Letter to the Court, (ECF No. 45), the Memorandum in Opposition filed by Sharon Rudderow, (ECF No. 55), the Memorandum in Opposition filed by Robert Rudderow, (ECF No. 56), Plaintiffs’ Exhibits to those Memoranda, (ECF No. 57), Plaintiffs’ Motion to File Extended Briefs, (ECF No. 62), Mazie Slater’s Reply Brief, (ECF No. 65), Adam M. Slater’s Certification in Support of that Reply, (ECF No. 65-1), the Exhibits to that

Certification, (ECF Nos. 65-2 to 65-8), the associated Proposed Order, (ECF No. 65-9), Plaintiffs’ Sur-Reply, Exhibits, and associated Proposed Order, (ECF No. 67), Plaintiffs’ Motion to File Supplemental Reply Brief and Exhibits, (ECF No. 69), Plaintiffs’ Opposition Letter Dated February 25, 2022, (ECF No. 76), and Plaintiffs’ Motion for Leave to File Out of Time, (ECF No. 71). The Court interprets Plaintiffs’ submissions as also opposing the Motion to Seal although the submissions are not entirely clear. (ECF No. 78).

2 Throughout the pendency of these Motions, Plaintiffs have indicated their intent to seek legal counsel to represent them and to oppose the Motions. The Court granted multiple requests for an extension of time for Plaintiffs to do so. (ECF Nos. 47, 53). The Court further held a hearing on January 10, 2022, (ECF Nos. 58, 60), in which Plaintiffs stated that the time was sufficient for them to obtain counsel. As of this date, Plaintiffs continue to appear pro se. Plaintiffs’ submissions exceed 200 pages and include arguments and materials that are substantially irrelevant to the pending Motions.3 The Court interprets Plaintiffs’ submissions as requesting that the fee on the excess portion of the settlement be 0%, (Sharon Rudderow’s Br. in Response to Motion to Set a Reasonable Fee, ECF No. 55, at 98), because Plaintiffs allege that

Mazie Slater pressured them into signing the settlement agreement, manipulated them throughout the settlement process, and refused to return their medical and legal files upon their request. (ECF Nos. 55, 56). Plaintiffs also allege that Mazie Slater failed to adequately represent their interests, engaged in unethical behavior, and is attempting to deceive and manipulate the Court. (ECF Nos. 55, 56). The Court has reviewed relevant email communications during the course of this litigation between Plaintiffs and Mazie Slater and, it is clear that there has been a substantial breakdown in the attorney-client relationship. (ECF Nos. 43, 55, 56, 57). As for the Motion to Seal, Plaintiffs request additional time to secure legal advice to determine how sealing the filings would impact their interest, citing concerns of HIPPA violations and what they allege to be their counsel’s attempt to deceive the Court. However, while seemingly

opposing the Motion to Seal, Plaintiffs request the redaction of their “identification, private communication, medical records, and private physician communication.” (Pla. Response to Motion to Seal, ECF No. 78, at 5).

3 Given Plaintiffs’ pro se status, the Court granted their request to file two overlength briefs in response to the Motion to Set a Reasonable Fee. (ECF Nos. 55, 56, 57, 63). Plaintiffs were advised, however, that no further briefings would be permitted and that additional filings not in compliance with Local Civil Rule 7.1 would be stricken. (ECF Nos. 82, 89). Numerous subsequent letters submitted by Plaintiffs were thereafter stricken. (ECF Nos. 81, 83, 84, 87, 88, 94, 95). III. LEGAL STANDARD A. Motion to Set a Reasonable Fee New Jersey Rule 1:21-7(c) governs the fee that an attorney may charge a client when the attorney represents the client in a personal injury action based on a contingent fee agreement. The

rule sets forth the maximum contingency fee an attorney may contract for in tort cases: (1) 33 1/3% on the first $750,000 recovered; (2) 30% on the next $750,000 recovered; (3) 25% on the next $750,000 recovered; (4) 20% on the next $750,000 recovered; and (5) on all amounts recovered in excess of the above by application for reasonable fee in accordance with the provisions of paragraph (f) hereof[.]

N.J.R. 1:21-7(c). Accordingly, Counsel must apply to the court for a “reasonable fee” on a recovery where the total amount of the excess $3,000,000. See N.J.R. 1:21-7(c). The amount of the fee in excess of $3,000,000 is to be determined by the court in light of all the circumstances. See King v. Cty. of Gloucester, 483 F. Supp. 2d 396, 398 (D.N.J. 2007) (citing Ehrlich v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

LEAP Systems, Inc. v. MoneyTrax, Inc.
638 F.3d 216 (Third Circuit, 2011)
Saffer v. Willoughby
670 A.2d 527 (Supreme Court of New Jersey, 1996)
Wurtzel v. Werres
493 A.2d 611 (New Jersey Superior Court App Division, 1985)
Ehrlich v. Kids of North Jersey, Inc.
769 A.2d 1081 (New Jersey Superior Court App Division, 2001)
King v. COUNTY OF GLOUCESTER
483 F. Supp. 2d 396 (D. New Jersey, 2007)
Buckelew v. Grossbard
461 A.2d 590 (New Jersey Superior Court App Division, 1983)
Bertolotti v. AutoZone, Inc.
132 F. Supp. 3d 590 (D. New Jersey, 2015)
Luchejko v. D. Membreno
475 A.2d 696 (New Jersey Superior Court App Division, 1983)

Cite This Page — Counsel Stack

Bluebook (online)
RUDDEROW v. BOSTON SCIENTIFIC CORPORATION, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rudderow-v-boston-scientific-corporation-njd-2022.